Facing pressure as consumers increasingly shop online for products traditionally bought at drugstores and as insurers pay pharmacies less to fill prescriptions, Walgreens’ earnings for the fiscal quarter that ended Nov. 30 sent its shares down by more than 5 percent.
Weak prescription volume was the biggest surprise of the first quarter, the company reportedly said on an earnings call.
Earnings per share were $1.37 versus an expected $1.41, and revenue was $34.3 billion versus an expected $34.6 billion.
CEO Stefano Pessina reportedly said that Walgreens still expects “roughly flat” adjusted earnings per share despite the company’s first-quarter performance.
“We are confident our strategic plans are the right ones to drive long-term sustainable growth going forward,” Pessina told CNBC.
Read the full article here.
More articles on pharmacy:
Walgreens secures enterprisewide specialty accreditation
Drug price hike update: Merck, Allergen, Novartis raise prices
Regeneron restructures, cuts at least 15 jobs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.